Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0015695 (
fatty liver
)
13,941
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
miR-223 is an important miRNA. It plays important roles in lipid metabolism by targeting related genes in mammals. It may be related to
fatty liver
in laying hens and its functions and target genes need further study. Through bioinformatics, we found that 349 genes were predicted as target genes of miR-223. Lipid-related gene
DAGLA
was among the predicted target genes. Dual-luciferase reporter assays showed that
DAGLA
was the target gene of miR-223 and the site mutation assays validated the target site of miR-223 in
DAGLA
. Overexpression of miR-223 in chicken hepatocytes LMH decreased the mRNA and protein expression of
DAGLA
, while knockdown of miR-223 increased expression of
DAGLA
in LMH cells, further indicating that miR-223 targets
DAGLA
and downregulates its expression. Since the target site of miR-223 in chicken
DAGLA
is not conserved, these findings suggest that miR-223 plays a specific role in chicken liver by regulating expression of target gene
DAGLA
.
...
PMID:Lipolytic gene DAGLA is targeted by miR-223 in chicken hepatocytes. 3299 47